Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Struck

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancer Research|September 1, 1982
Disposition and metabolism of the carcinogen reduced Michler's ketone in ratsD J McCarthy, R F Struck, T W Shih, et al.
Cancer Research|October 1, 1984
Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450A J Marinello, S K Bansal, B Paul, et al.
Journal of the National Cancer Institute|December 4, 1991
Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trialD S Alberts, N Mason-Liddil, P M Plezia, et al.
Biochemical and Biophysical Research Communications|April 30, 1984
Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated ratsR F Struck, P Kari, J Kalin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1S M el Dareer, K F Tillery, L M Rose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research|March 1, 1997
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedineW R Waud, A Tiwari, S M Schmid, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeysS M El Dareer, R F Struck, K F Tillery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Tissue and tumor distribution of C-penclomedine in ratsS O'Reilly, N R Hartman, S A Grossman, et al.
Biochemical Pharmacology|June 1, 1982
Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agentR F Struck, A T Shortnacy, M C Kirk, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Research|September 1, 1982
Disposition and metabolism of the carcinogen reduced Michler's ketone in ratsD J McCarthy, R F Struck, T W Shih, et al.
Cancer Research|October 1, 1984
Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450A J Marinello, S K Bansal, B Paul, et al.
Journal of the National Cancer Institute|December 4, 1991
Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trialD S Alberts, N Mason-Liddil, P M Plezia, et al.
Biochemical and Biophysical Research Communications|April 30, 1984
Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated ratsR F Struck, P Kari, J Kalin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1S M el Dareer, K F Tillery, L M Rose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research|March 1, 1997
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedineW R Waud, A Tiwari, S M Schmid, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeysS M El Dareer, R F Struck, K F Tillery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Tissue and tumor distribution of C-penclomedine in ratsS O'Reilly, N R Hartman, S A Grossman, et al.
Biochemical Pharmacology|June 1, 1982
Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agentR F Struck, A T Shortnacy, M C Kirk, et al.
Pageof 6